EDESA BIOTECH, INC. (EDSA) Operating cash flow 2016–2025
EDESA BIOTECH, INC. (EDSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.3MFY2025 · since FY2016: -$4.5M → -$7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.3M | -49.7% |
| FY2024 | -$4.9M | +26.3% |
| FY2023 | -$6.6M | +46.0% |
| FY2022 | -$12.3M | +10.1% |
| FY2021 | -$13.7M | -174.0% |
| FY2020 | -$5.0M | — |
| FY2018 | -$1.3M | +72.6% |
| FY2017 | -$4.7M | -4.3% |
| FY2016 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EDSA financial trends
EDSA RevenueEDSA Net incomeEDSA Net marginEDSA Gross profitEDSA Gross marginEDSA Operating incomeEDSA Operating marginEDSA Free cash flowEDSA Capital expendituresEDSA Return on equityEDSA Stock buybacksEDSA Dividends paidEDSA Total assetsEDSA Total liabilitiesEDSA Shareholders’ equityEDSA overview →